Company news

Sernova Biotherapeutics Inc news in 2018

Sernova Biotherapeutics Inc's news releases, calls and decks from 2018, newest first.

View company

Sernova Announces Enrollment of First Patient in U.S. Phase I/II Study of Cell Pouch(tm) for Treatment in Type 1 Diabetes

December 20, 2018

Sernova Highlights Achievements from the HemAcure Consortium in Developing a Novel Cell-Based Therapy for Hemophilia A

November 20, 2018

Sernova Retains FronTier Flex for Canadian Investor Relations and Marketing

November 9, 2018

Sernova Establishes Comprehensive North American Investor Relations and Communications Strategy

November 6, 2018

Sernova-HemAcure Consortium to Present Achievements in Development of a Regenerative Medicine Approach to Treat Hemophilia A

October 23, 2018

Sernova Obtains FDA Notice of Allowance for Use of Proprietary Cell Pouch System with Continuous Glucose Monitoring Systems in Clinical Trials for Type 1 Diabetes - Video Available on Investmentpitch.com

February 23, 2018

Decks in 2018